Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Leigh Perreault

Concepts (338)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prediabetic State
25
2026
250
6.510
Why?
Diabetes Mellitus, Type 2
51
2026
2602
4.660
Why?
Insulin Resistance
34
2025
1244
3.920
Why?
Obesity
32
2026
3118
3.300
Why?
Hypoglycemic Agents
23
2023
1399
2.810
Why?
Weight Loss
18
2026
859
2.430
Why?
Blood Glucose
32
2026
2344
2.360
Why?
Primary Health Care
9
2026
1737
2.160
Why?
Weight Reduction Programs
4
2026
140
2.130
Why?
Muscle, Skeletal
22
2025
1791
2.100
Why?
Cardiovascular Diseases
15
2020
2191
1.870
Why?
Insulin
20
2024
2516
1.660
Why?
Sphingolipids
7
2024
83
1.560
Why?
Obesity Management
2
2026
12
1.510
Why?
Diabetes Mellitus
11
2023
1101
1.490
Why?
Triglycerides
11
2024
520
1.470
Why?
Glucose Intolerance
8
2020
142
1.350
Why?
Benzhydryl Compounds
3
2017
81
1.350
Why?
Diabetic Angiopathies
3
2017
267
1.330
Why?
Diglycerides
6
2024
61
1.210
Why?
Diabetes Complications
2
2019
225
1.040
Why?
Overweight
7
2022
614
1.000
Why?
Glucosides
2
2017
56
1.000
Why?
Glucagon-Like Peptide 1
3
2023
149
0.920
Why?
Life Style
12
2020
486
0.920
Why?
Exercise
12
2025
2205
0.870
Why?
Metformin
13
2023
329
0.850
Why?
Receptors, Gastrointestinal Hormone
1
2023
7
0.800
Why?
Glucose Tolerance Test
15
2021
361
0.790
Why?
Humans
101
2026
145783
0.790
Why?
Adipose Tissue
5
2025
645
0.780
Why?
Anti-Obesity Agents
2
2024
67
0.780
Why?
Adult
57
2025
40881
0.770
Why?
Glucose Clamp Technique
11
2024
199
0.760
Why?
Cannabidiol
1
2025
142
0.740
Why?
Goals
2
2021
185
0.730
Why?
Dronabinol
1
2025
249
0.710
Why?
Middle Aged
47
2025
36309
0.700
Why?
Nutrition Therapy
1
2022
37
0.690
Why?
Marijuana Use
1
2025
222
0.670
Why?
Male
63
2026
73010
0.660
Why?
Body Mass Index
13
2025
2447
0.660
Why?
Liver
4
2014
1899
0.650
Why?
Female
68
2026
79045
0.640
Why?
Health Equity
1
2023
133
0.640
Why?
Primary Care Nursing
1
2019
4
0.620
Why?
Hyperglycemia
4
2014
380
0.600
Why?
Weight Gain
5
2025
561
0.570
Why?
Lipid Metabolism
5
2025
529
0.560
Why?
Peripheral Vascular Diseases
1
2019
104
0.560
Why?
Insulin, Long-Acting
1
2019
65
0.560
Why?
Infant, Newborn, Diseases
1
2019
115
0.540
Why?
Microvessels
1
2019
97
0.540
Why?
Cannabis
1
2025
510
0.530
Why?
Awareness
1
2019
110
0.530
Why?
Fasting
4
2020
279
0.520
Why?
Policy
1
2018
149
0.510
Why?
Ceramides
5
2024
117
0.510
Why?
Risk Factors
20
2026
10919
0.500
Why?
Risk Management
1
2017
82
0.500
Why?
Precision Medicine
1
2021
461
0.490
Why?
Incretins
2
2021
21
0.480
Why?
Colorado
6
2026
4556
0.480
Why?
Rest
2
2017
126
0.470
Why?
Choristoma
1
2015
20
0.460
Why?
Sleep Deprivation
5
2021
206
0.440
Why?
Insulin-Secreting Cells
2
2010
392
0.430
Why?
Inflammation
1
2025
2884
0.390
Why?
Electronic Health Records
3
2026
1202
0.390
Why?
Sarcolemma
3
2024
35
0.390
Why?
Glucose
4
2023
1049
0.370
Why?
Phenols
1
2013
106
0.370
Why?
Clinical Trials as Topic
1
2017
1062
0.360
Why?
Randomized Controlled Trials as Topic
4
2022
1752
0.360
Why?
Lipids
4
2024
707
0.350
Why?
Aged
18
2025
26217
0.340
Why?
Physical Endurance
5
2020
279
0.330
Why?
Fenofibrate
1
2011
28
0.330
Why?
Athletes
7
2024
425
0.320
Why?
Hypolipidemic Agents
1
2011
89
0.310
Why?
Glucagon-Like Peptides
2
2022
71
0.310
Why?
Phosphatidylcholines
2
2024
131
0.310
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2010
46
0.310
Why?
Palmitates
1
2009
21
0.310
Why?
Pyrazines
1
2010
94
0.300
Why?
Cross-Sectional Studies
9
2024
5925
0.300
Why?
Hospitalization
1
2019
2461
0.290
Why?
Triazoles
1
2010
191
0.280
Why?
Energy Metabolism
4
2021
935
0.280
Why?
Young Adult
13
2025
14254
0.270
Why?
Biomarkers
8
2023
4302
0.270
Why?
Sleep
4
2021
889
0.260
Why?
Risk Reduction Behavior
3
2023
217
0.260
Why?
Sodium-Glucose Transporter 2
2
2017
29
0.250
Why?
Diabetic Nephropathies
2
2020
322
0.250
Why?
Sex Characteristics
3
2021
789
0.240
Why?
Markov Chains
2
2018
132
0.240
Why?
Absenteeism
2
2018
52
0.240
Why?
Clinical Coding
1
2026
29
0.240
Why?
Double-Blind Method
5
2024
2064
0.240
Why?
Sex Factors
5
2018
2110
0.230
Why?
Health Services
2
2018
113
0.230
Why?
Adiponectin
3
2018
242
0.230
Why?
Muscle Fibers, Skeletal
3
2024
212
0.220
Why?
Remission Induction
3
2019
306
0.220
Why?
Follow-Up Studies
6
2021
5428
0.210
Why?
Pilot Projects
2
2021
1898
0.210
Why?
Renal Insufficiency, Chronic
2
2022
668
0.210
Why?
Carnitine
2
2024
91
0.210
Why?
Circadian Rhythm
3
2019
513
0.200
Why?
Lipogenesis
2
2017
62
0.200
Why?
Dietary Fats
3
2020
308
0.200
Why?
Lipoprotein Lipase
1
2004
56
0.200
Why?
United States
10
2026
16126
0.200
Why?
Cross-Over Studies
1
2026
610
0.200
Why?
Hyperinsulinism
1
2024
115
0.190
Why?
Physical Exertion
1
2004
205
0.190
Why?
Oxidation-Reduction
4
2024
1069
0.190
Why?
Healthy Lifestyle
1
2023
37
0.190
Why?
Computer Simulation
2
2018
1003
0.180
Why?
Diet, Reducing
3
2017
91
0.180
Why?
Socioeconomic Factors
2
2018
1327
0.180
Why?
Energy Intake
4
2021
512
0.180
Why?
Biopsy
3
2018
1082
0.180
Why?
Combined Modality Therapy
4
2019
1271
0.180
Why?
Cluster Analysis
1
2023
501
0.170
Why?
Endpoint Determination
2
2019
85
0.170
Why?
Dose-Response Relationship, Drug
3
2024
2028
0.170
Why?
Nephrology
1
2022
60
0.170
Why?
Glucose Transporter Type 4
1
2021
39
0.170
Why?
Prevalence
2
2019
2875
0.170
Why?
Cytosol
2
2020
213
0.170
Why?
Body Weight
4
2024
972
0.160
Why?
Ambulatory Care Facilities
1
2023
269
0.160
Why?
Risk Adjustment
1
2020
85
0.160
Why?
Endocrinologists
1
2020
12
0.150
Why?
New Zealand
1
2019
55
0.150
Why?
Cytosine
1
2019
49
0.150
Why?
Endoplasmic Reticulum
2
2020
264
0.150
Why?
Pragmatic Clinical Trials as Topic
1
2019
133
0.150
Why?
Fatty Acids, Nonesterified
2
2019
154
0.140
Why?
Fatty Liver
1
2021
253
0.140
Why?
Liraglutide
1
2019
32
0.140
Why?
Exercise Test
3
2015
630
0.140
Why?
Models, Econometric
1
2018
35
0.140
Why?
Retinal Diseases
1
2019
101
0.140
Why?
Postprandial Period
1
2019
114
0.130
Why?
Quinolizines
1
1997
9
0.130
Why?
Adolescent
8
2023
22577
0.130
Why?
Drug Combinations
1
2019
396
0.130
Why?
Nausea
1
1997
112
0.130
Why?
Antiemetics
1
1997
51
0.130
Why?
Cytokines
1
2025
2069
0.130
Why?
Tissue Plasminogen Activator
2
2018
248
0.130
Why?
Cholesterol, HDL
2
2015
201
0.130
Why?
Health Resources
1
2018
130
0.130
Why?
Vomiting
1
1997
131
0.120
Why?
Severity of Illness Index
2
2018
2933
0.120
Why?
Hysterectomy
1
1997
138
0.120
Why?
Referral and Consultation
1
2023
869
0.120
Why?
Odds Ratio
1
2019
1083
0.120
Why?
Patient-Centered Care
1
2021
547
0.120
Why?
Surgical Wound Infection
1
2019
329
0.120
Why?
Delivery of Health Care
1
2023
948
0.120
Why?
Blotting, Western
2
2016
1184
0.120
Why?
Phosphatidylethanolamines
1
2016
77
0.120
Why?
Patient Participation
1
2019
446
0.120
Why?
Phenotype
1
2024
3170
0.110
Why?
Eating
2
2021
387
0.110
Why?
Research Design
2
2019
1139
0.110
Why?
Tandem Mass Spectrometry
2
2024
572
0.110
Why?
Cost-Benefit Analysis
1
2018
644
0.110
Why?
Kidney Diseases
1
2019
426
0.110
Why?
Treatment Outcome
6
2021
11794
0.110
Why?
Exercise Therapy
2
2017
475
0.110
Why?
Costs and Cost Analysis
1
2015
221
0.110
Why?
Patient Compliance
1
2019
588
0.110
Why?
Income
1
2015
203
0.100
Why?
Sleep Apnea Syndromes
1
2015
98
0.100
Why?
Somatostatin
1
2014
53
0.100
Why?
Hypoglycemia
1
2019
480
0.100
Why?
Logistic Models
1
2019
2139
0.100
Why?
Smoking
2
2012
1477
0.100
Why?
Indoles
1
1997
507
0.100
Why?
Pneumonia
1
2019
636
0.100
Why?
Employment
1
2015
184
0.100
Why?
Fructose
1
2014
132
0.100
Why?
Recovery of Function
2
2015
716
0.100
Why?
Metabolic Diseases
1
2014
114
0.090
Why?
Health Personnel
1
2019
757
0.090
Why?
Cost of Illness
1
2015
324
0.090
Why?
C-Reactive Protein
1
2015
423
0.090
Why?
Oxygen Consumption
4
2016
719
0.090
Why?
Fatty Acids, Monounsaturated
1
2012
55
0.090
Why?
Multicenter Studies as Topic
1
2014
413
0.090
Why?
Models, Theoretical
1
2016
560
0.090
Why?
Homeostasis
1
2016
644
0.090
Why?
Qualitative Research
1
2019
1683
0.090
Why?
Aged, 80 and over
3
2019
8347
0.090
Why?
Adult Children
1
2011
27
0.090
Why?
Placebos
2
2009
193
0.080
Why?
Prospective Studies
3
2019
8078
0.080
Why?
Diabetes, Gestational
1
2015
306
0.080
Why?
Mitochondria
1
2018
993
0.080
Why?
Practice Guidelines as Topic
1
2019
1582
0.080
Why?
Adipocytes
1
2012
223
0.080
Why?
Age Factors
1
2018
3346
0.080
Why?
Health Behavior
2
2023
791
0.080
Why?
Sitagliptin Phosphate
1
2010
31
0.080
Why?
Family Health
1
2011
191
0.080
Why?
Comorbidity
1
2015
1662
0.080
Why?
Health Knowledge, Attitudes, Practice
1
2019
1420
0.080
Why?
Metabolomics
1
2015
733
0.080
Why?
Longevity
1
2011
178
0.080
Why?
Mitochondria, Muscle
2
2021
120
0.070
Why?
C-Peptide
1
2010
190
0.070
Why?
Quality of Life
3
2019
3211
0.070
Why?
Disease Progression
3
2024
2865
0.070
Why?
Leisure Activities
1
2008
31
0.070
Why?
Menopause
1
2011
326
0.070
Why?
Blood Pressure
1
2014
1782
0.060
Why?
Delphi Technique
2
2019
333
0.060
Why?
Consensus
2
2020
479
0.060
Why?
Body Composition
1
2011
693
0.060
Why?
Predictive Value of Tests
1
2012
2123
0.060
Why?
Risk Assessment
3
2015
3752
0.060
Why?
Fibrinogen
2
2018
180
0.060
Why?
Cohort Studies
4
2021
6033
0.060
Why?
Multivariate Analysis
1
2009
1547
0.060
Why?
Regression Analysis
2
2019
1001
0.060
Why?
Diabetes Mellitus, Type 1
2
2012
3937
0.050
Why?
Mass Screening
1
2013
1361
0.050
Why?
Postoperative Complications
1
1997
2977
0.050
Why?
Aging
1
2015
1973
0.050
Why?
Metabolic Clearance Rate
1
2004
115
0.050
Why?
Health Expenditures
1
1986
194
0.050
Why?
Gene Expression Profiling
2
2023
1777
0.050
Why?
Incidence
3
2019
2934
0.050
Why?
Hormones
1
2004
135
0.050
Why?
Prognosis
2
2023
4330
0.050
Why?
Menstrual Cycle
1
2003
145
0.050
Why?
Depression
1
2012
1559
0.050
Why?
Retrospective Studies
2
2019
17330
0.050
Why?
Parents
1
2011
1407
0.050
Why?
Eligibility Determination
1
2023
72
0.050
Why?
Gastrointestinal Diseases
1
2024
222
0.050
Why?
Mice, Inbred C57BL
1
2013
5992
0.040
Why?
Alcohol Drinking
1
2009
843
0.040
Why?
Lactic Acid
1
2003
295
0.040
Why?
Wakefulness
2
2015
170
0.040
Why?
Animals
3
2024
38101
0.040
Why?
Proportional Hazards Models
2
2017
1330
0.040
Why?
Acute Disease
1
2024
1036
0.040
Why?
Subcellular Fractions
1
2021
73
0.040
Why?
Citric Acid Cycle
1
2021
58
0.040
Why?
Kinetics
1
2004
1568
0.040
Why?
Sex Hormone-Binding Globulin
1
2020
52
0.040
Why?
Injections, Subcutaneous
1
2021
170
0.040
Why?
Motor Activity
2
2015
718
0.040
Why?
Protective Agents
1
2020
42
0.040
Why?
Education
1
2020
105
0.040
Why?
Stearoyl-CoA Desaturase
2
2010
66
0.040
Why?
Proprotein Convertase 9
1
2020
87
0.040
Why?
Analysis of Variance
2
2013
1300
0.040
Why?
Poisson Distribution
1
2019
78
0.040
Why?
Stakeholder Participation
1
2019
85
0.040
Why?
E-Selectin
1
2018
61
0.040
Why?
Time Factors
3
2019
7134
0.040
Why?
Subcutaneous Fat
1
2019
79
0.030
Why?
Probability
1
2019
308
0.030
Why?
Intercellular Adhesion Molecule-1
1
2018
132
0.030
Why?
Pregnancy
2
2015
7216
0.030
Why?
Chemokine CCL2
1
2018
112
0.030
Why?
Primary Cell Culture
1
2019
172
0.030
Why?
Intra-Abdominal Fat
1
2019
101
0.030
Why?
Cell Nucleus
1
2020
588
0.030
Why?
Research
1
2020
431
0.030
Why?
Leptin
1
2018
248
0.030
Why?
Diet
3
2012
1278
0.030
Why?
Case-Control Studies
2
2017
3634
0.030
Why?
Biological Transport
1
2017
424
0.030
Why?
Sequence Analysis, RNA
1
2019
442
0.030
Why?
Adaptation, Physiological
2
2010
560
0.030
Why?
Metabolome
1
2019
391
0.030
Why?
Rats
1
2024
5585
0.030
Why?
Fatty Acids, Unsaturated
1
2016
96
0.030
Why?
Diet, Fat-Restricted
1
2015
79
0.030
Why?
Melatonin
1
2015
163
0.030
Why?
Longitudinal Studies
2
2013
2968
0.030
Why?
Interleukin-6
1
2018
780
0.030
Why?
Blood Glucose Self-Monitoring
1
2020
701
0.030
Why?
Kidney
1
2022
1497
0.030
Why?
Calorimetry
1
2013
69
0.020
Why?
Fatty Acids
1
2016
457
0.020
Why?
Insulin Receptor Substrate Proteins
1
2012
55
0.020
Why?
Risk
1
2015
923
0.020
Why?
Glycerol
1
2012
90
0.020
Why?
Algorithms
1
2020
1851
0.020
Why?
RNA, Messenger
2
2010
2805
0.020
Why?
Sleep Wake Disorders
1
2015
314
0.020
Why?
Calorimetry, Indirect
1
2010
72
0.020
Why?
Genetic Variation
1
2015
977
0.020
Why?
Antidepressive Agents
1
2012
242
0.020
Why?
Palmitic Acid
1
2010
40
0.020
Why?
Nicotine
1
2012
331
0.020
Why?
Surveys and Questionnaires
1
2022
6085
0.020
Why?
Retinoid X Receptor gamma
1
2009
5
0.020
Why?
Gene Expression Regulation
1
2019
2601
0.020
Why?
PPAR alpha
1
2009
55
0.020
Why?
Polysomnography
1
2010
239
0.020
Why?
TOR Serine-Threonine Kinases
1
2012
456
0.020
Why?
Bicycling
1
2010
117
0.020
Why?
Women's Health
1
2011
316
0.020
Why?
Coronary Disease
1
2011
382
0.020
Why?
Phospholipids
1
2010
214
0.020
Why?
Phosphorylation
1
2012
1708
0.020
Why?
Reference Values
1
2009
798
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
979
0.020
Why?
Adiposity
1
2012
532
0.020
Why?
Genetic Predisposition to Disease
1
2015
2399
0.020
Why?
Mice
1
2024
18355
0.020
Why?
Patient Education as Topic
1
2011
777
0.010
Why?
Genotype
1
2011
1857
0.010
Why?
Infant Care
1
1986
44
0.010
Why?
Infertility
1
1986
61
0.010
Why?
Health Promotion
1
2011
775
0.010
Why?
Delivery, Obstetric
1
1986
160
0.010
Why?
Maternal Health Services
1
1986
101
0.010
Why?
Follicular Phase
1
2003
41
0.010
Why?
Anaerobic Threshold
1
2003
28
0.010
Why?
Spectrophotometry, Ultraviolet
1
2003
81
0.010
Why?
Luteal Phase
1
2003
51
0.010
Why?
Contraception
1
1986
170
0.010
Why?
Catecholamines
1
2003
88
0.010
Why?
Abortion, Induced
1
1986
112
0.010
Why?
Polymorphism, Single Nucleotide
1
2011
2181
0.010
Why?
Heart Rate
1
2003
856
0.010
Why?
Infant, Newborn
1
1986
6465
0.010
Why?
Perreault's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)